Advanced Tumor Marker Testing
PSA, CA125 & CA19.9 | Expert Cancer Screening in Dubai
Termin vereinbaren
Verifizierte Patientenbewertungen des DCDC Diagnosezentrum in Dubai
Verifizierte Bewertungen und echte Patientenberichte aus Dubai Healthcare City
Ich bin sehr zufrieden mit dieser medizinischen Klinik. Ich hatte hier mein erstes Schwangerschaftsscreening. Es war erschwinglich und sehr professionell. Der Radiologe war einladend, freundlich und machte die Erfahrung großartig.
Aizhan Tokmanbetova
Am Freitagabend habe ich mir das Knie verletzt und am Sonntagabend einen MRT-Termin bekommen (am Sonntagnachmittag gebucht). Ich habe etwa 2 Minuten gewartet und war in etwas mehr als 30 Minuten fertig. Das Team war erstaunlich, freundlich und effizient.
Kirsten Evans
Das Team von Dr. Osama war sanft und erstaunlich. Nach einer schlechten Erfahrung anderswo war meine Beckenuntersuchung hier viel professioneller. Toller Bericht und sehr präzise.
Mary
Tumor Markers Blood Test in Dubai: PSA, CA125 & CA19.9 Screening
Early detection through accurate cancer marker analysis at DHCC
Focused Panel
PSA, CA125, and CA19.9 — the most validated cancer screening markers
Early Detection
Identify potential malignancies before symptoms develop
Fast Results
Most tumor marker results available within 24-48 hours
Specialist Pathway
Direct referral to oncology, gynaecology, or urology if needed
Cancer remains one of the leading causes of morbidity and mortality in the United Arab Emirates, with prostate, ovarian, and gastrointestinal malignancies accounting for a significant proportion of diagnoses. According to the UAE National Cancer Registry, cancer incidence has risen steadily over the past decade, driven by population growth, changing lifestyles, and increased diagnostic awareness. Tumor marker blood tests play a vital role in the early detection and monitoring of these cancers, offering a non-invasive first step that can prompt timely specialist referral and potentially life-saving intervention.
Tumor markers are substances, usually proteins, produced by cancer cells or by the body in response to cancer. While no single tumor marker provides a definitive cancer diagnosis on its own, these biomarkers are invaluable tools when combined with clinical history, imaging, and physical examination. At DCDC in Dubai Healthcare City, we offer a focused panel of the most clinically validated tumor markers: Total PSA for prostate cancer screening, CA125 for ovarian cancer assessment, and CA19.9 for pancreatic and gastrointestinal cancer evaluation. Each marker serves a distinct clinical purpose and is interpreted within the context of the individual patient.
Focused Panel
PSA, CA125, and CA19.9 — the most validated cancer screening markers
Early Detection
Identify potential malignancies before symptoms develop
Fast Results
Most tumor marker results available within 24-48 hours
Specialist Pathway
Direct referral to oncology, gynaecology, or urology if needed
Tumor Markers Blood Test in Dubai: PSA, CA125 & CA19.9 Screening
Early detection through accurate cancer marker analysis at DHCC
Cancer remains one of the leading causes of morbidity and mortality in the United Arab Emirates, with prostate, ovarian, and gastrointestinal malignancies accounting for a significant proportion of diagnoses. According to the UAE National Cancer Registry, cancer incidence has risen steadily over the past decade, driven by population growth, changing lifestyles, and increased diagnostic awareness. Tumor marker blood tests play a vital role in the early detection and monitoring of these cancers, offering a non-invasive first step that can prompt timely specialist referral and potentially life-saving intervention.
Tumor markers are substances, usually proteins, produced by cancer cells or by the body in response to cancer. While no single tumor marker provides a definitive cancer diagnosis on its own, these biomarkers are invaluable tools when combined with clinical history, imaging, and physical examination. At DCDC in Dubai Healthcare City, we offer a focused panel of the most clinically validated tumor markers: Total PSA for prostate cancer screening, CA125 for ovarian cancer assessment, and CA19.9 for pancreatic and gastrointestinal cancer evaluation. Each marker serves a distinct clinical purpose and is interpreted within the context of the individual patient.
Dr. Hadi Komshi
Unsere Tumor Markers Leistungen
Umfassende tumor markers Leistungen im DCDC Dubai Healthcare City.
PSA Testing
Total PSA for prostate cancer screening and monitoring in men over 40.
CA125 Testing
Ovarian cancer marker for risk assessment, diagnosis support, and treatment monitoring.
CA19.9 Testing
Pancreatic and gastrointestinal cancer marker for evaluation and follow-up.
Comprehensive Cancer Screening Panel
Combined PSA, CA125, and CA19.9 panel for thorough cancer marker evaluation.
Alle Leistungen werden von DHA-lizenzierten Spezialisten durchgeführt
Für wen ist Tumor Markers geeignet?
Tumor marker testing is recommended for individuals with risk factors for cancer, those with symptoms that may suggest malignancy, and patients undergoing cancer treatment monitoring. Your physician may order these tests based on clinical findings, family history, or screening guidelines.
Men over 50, or over 40 with family history of prostate cancer, for PSA screening
Women with pelvic masses, bloating, or family history of ovarian cancer for CA125
Patients with unexplained abdominal pain, weight loss, or jaundice for CA19.9
Individuals with a first-degree relative diagnosed with prostate, ovarian, or pancreatic cancer
Patients with known cancer undergoing treatment for response monitoring
Post-treatment cancer survivors for recurrence surveillance
Why Choose DCDC for Tumor Marker Testing?
MOHAP-licensed laboratory with advanced immunoassay technology, rapid turnaround, and integrated specialist referral pathways for comprehensive cancer screening.
MOHAP Licensed
Accredited diagnostic laboratory with certified tumor marker testing protocols and quality assurance.
Rapid Results
Most tumor marker results ready within 24-48 hours for timely clinical decision-making.
Insurance Support
Direct billing with 20+ insurers. Tumor markers typically covered with physician referral.
Convenient Location
Building 64, Block A in Dubai Healthcare City. Walk-ins welcome with appointment preferred.
Advanced Immunoassay
State-of-the-art analyzers calibrated to international reference standards for reliable results.
Specialist Integration
On-site internists, gynaecologists, and urologists for immediate follow-up of abnormal findings.
Ihr angenehmer Besuch
Ein einfacher, schrittweiser Tumor-Untersuchungsprozess für Komfort, Schnelligkeit und Genauigkeit.
Tumor Marker Testing Pricing
Die Tumor-Preise in Dubai variieren je nach Leistungsart und Versicherungsdeckung für verschiedene Leistungstypen.
- Preise variieren je nach Untersuchungsart und Kontrastmittelbedarf
- Versicherungsdeckung akzeptiert mit Überweisung und Verifizierung
- Transparente Selbstzahlerpreise mit sofortigem Angebot auf Anfrage
Versicherungsverifizierung in Minuten • Keine versteckten Gebühren • Schnelle Antwort auf WhatsApp
Patientenratgeber
What to Expect During Tumor Marker Testing
A simple blood draw with minimal preparation and fast turnaround.
Versicherung & Standort
Versicherungspartner
- •Über 20 Versicherungsanbieter in Dubai einschließlich Daman, AXA, ADNIC und andere
- •Vorabgenehmigung-Unterstützung und Direktabrechnung (falls zutreffend)
- •Deckungsüberprüfung vor Ihrem Termin in unserer Klinik in Dubai Healthcare City
- •Transparente Preisgestaltung ohne versteckte Gebühren für tumor markers-Leistungen
Besuchen Sie uns in Dubai Healthcare City
Doctors Clinic Diagnostic Center
Gebäude 64, Block A, Al Razi Medical Complex, Dubai Healthcare City, Dubai, VAE
Nahe der Oud Metha Road · Einfacher Zugang von Bur Dubai, Downtown Dubai, Business Bay · Kostenlose Patientenparkplätze verfügbar
Öffnungszeiten
Sa-Do: 8:00 - 22:00 Uhr | Fr: 9:00 - 21:00 Uhr
So funktioniert die Versicherung bei DCDC
Deckung prüfen
Überprüfen Sie, ob Ihr Plan Tumor Markers abdeckt
Überweisung erhalten
Einige Versicherer verlangen eine Überweisung — wir helfen Ihnen gerne
Vorab-Genehmigung
Wir übernehmen die Vorab-Genehmigung direkt mit Ihrem Versicherer
Direktabrechnung
Keine Vorauszahlung — wir rechnen direkt mit Ihrem Versicherer ab
Nur Eigenanteil
Sie zahlen nur den anfallenden Eigenanteil in der Klinik
Deckung prüfen
Überprüfen Sie, ob Ihr Plan Tumor Markers abdeckt
Überweisung erhalten
Einige Versicherer verlangen eine Überweisung — wir helfen Ihnen gerne
Vorab-Genehmigung
Wir übernehmen die Vorab-Genehmigung direkt mit Ihrem Versicherer
Direktabrechnung
Keine Vorauszahlung — wir rechnen direkt mit Ihrem Versicherer ab
Nur Eigenanteil
Sie zahlen nur den anfallenden Eigenanteil in der Klinik
Ihr Spezialist
Dr. Hadi Komshi
Specialist Internal Medicine
MD, Specialist Internal Medicine
Persisch · Arabisch · Englisch
Conditions and Cancers Assessed Through Tumor Markers
Prostate Cancer
PSA is the primary screening and monitoring marker for prostate cancer, the most common non-skin cancer in men.
Ovarian Cancer
CA125 is used to evaluate suspected ovarian masses, monitor treatment response in diagnosed ovarian cancer, and surveil high-risk women with BRCA mutations or strong family history.
Pancreatic Cancer
CA19.9 supports the diagnosis and monitoring of pancreatic adenocarcinoma, with elevated levels correlating with tumor burden and helping predict surgical resectability.
Colorectal Cancer
CA19.9 may be elevated in colorectal malignancies and is sometimes used alongside CEA for monitoring treatment response and detecting recurrence.
Verwandte Leistungen
Entdecken Sie weitere Diagnose- und Beratungsleistungen in unserer Klinik in Dubai Healthcare City.
Häufig gestellte Fragen
Häufige Fragen zu Tumor Markers in Dubai.
Tumor markers are proteins produced by cancer cells or the body in response to cancer, measured through a blood test. They serve four functions: screening at-risk individuals, supporting diagnosis, monitoring treatment effectiveness, and detecting recurrence.
PSA (Prostate Specific Antigen) is produced by normal and cancerous prostate cells. Below 4.0 ng/mL is generally normal; 4.0-10.0 is a grey zone where approximately 25 percent may have cancer; above 10.0 carries higher probability.
CA125 is a protein elevated in ovarian cancer (80 percent of advanced cases) but also in endometriosis, fibroids, PID, and menstruation. It is most useful for evaluating women with persistent bloating, pelvic pain, or difficulty eating, and for monitoring diagnosed ovarian cancer.
CA19.9 is a protein shed by pancreatic and GI cancer cells. Below 37 U/mL is generally normal; above 100 U/mL is associated with pancreatic cancer.
Yes. PSA is elevated by BPH, prostatitis, and cycling.
Wichtige Fakten
Medizinische Aufsicht
Alle Leistungen werden unter Aufsicht lizenzierter medizinischer Fachkräfte in unserer MOHAP-akkreditierten Einrichtung erbracht.